140 related articles for article (PubMed ID: 32069515)
1. Fibrinolysis and the Immune Response in Trauma.
Medcalf RL; Keragala CB; Draxler DF
Semin Thromb Hemost; 2020 Mar; 46(2):176-182. PubMed ID: 32069515
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolysis and antifibrinolytic treatment in the trauma patient.
Gall LS; Davenport RA
Curr Opin Anaesthesiol; 2018 Apr; 31(2):227-233. PubMed ID: 29324486
[TBL] [Abstract][Full Text] [Related]
3. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
4. Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?
Moore HB; Moore EE; Chapman MP; Hansen KC; Cohen MJ; Pieracci FM; Chandler J; Sauaia A
J Am Coll Surg; 2019 Jul; 229(1):92-101. PubMed ID: 30936005
[TBL] [Abstract][Full Text] [Related]
5. The fibrinolytic system-more than fibrinolysis?
Draxler DF; Medcalf RL
Transfus Med Rev; 2015 Apr; 29(2):102-9. PubMed ID: 25576010
[TBL] [Abstract][Full Text] [Related]
6. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V
Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724
[TBL] [Abstract][Full Text] [Related]
7. The Central Role of Fibrinolytic Response in Trauma-Induced Coagulopathy: A Hematologist's Perspective.
Kwaan HC
Semin Thromb Hemost; 2020 Mar; 46(2):116-124. PubMed ID: 31877570
[TBL] [Abstract][Full Text] [Related]
8. What drives "fibrinolysis"?
Medcalf RL
Hamostaseologie; 2015; 35(4):303-10. PubMed ID: 25564072
[TBL] [Abstract][Full Text] [Related]
9. Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock.
Gando S; Otomo Y
Crit Care; 2015 Feb; 19(1):72. PubMed ID: 25886801
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolysis in trauma: a review.
Madurska MJ; Sachse KA; Jansen JO; Rasmussen TE; Morrison JJ
Eur J Trauma Emerg Surg; 2018 Feb; 44(1):35-44. PubMed ID: 28918481
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Treatment of Hyperfibrinolysis in Trauma (A European Perspective).
Gall LS; Brohi K; Davenport RA
Semin Thromb Hemost; 2017 Mar; 43(2):224-234. PubMed ID: 28219084
[TBL] [Abstract][Full Text] [Related]
12. Trending Fibrinolytic Dysregulation: Fibrinolysis Shutdown in the Days After Injury Is Associated With Poor Outcome in Severely Injured Children.
Leeper CM; Neal MD; McKenna CJ; Gaines BA
Ann Surg; 2017 Sep; 266(3):508-515. PubMed ID: 28650356
[TBL] [Abstract][Full Text] [Related]
13. Temporal Changes in Fibrinolysis following Injury.
Moore HB; Moore EE
Semin Thromb Hemost; 2020 Mar; 46(2):189-198. PubMed ID: 32160644
[TBL] [Abstract][Full Text] [Related]
14. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
Sindet-Pedersen S
Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
[TBL] [Abstract][Full Text] [Related]
15. Mafenide (Sulfamylon) inhibits plasmin fibrinolytic activity.
Weisdorf DJ; Aldridge JH
Thromb Haemost; 1988 Jun; 59(3):440-4. PubMed ID: 2973151
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
Jespersen J
Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
[TBL] [Abstract][Full Text] [Related]
17. Plasmin: A Modulator of Immune Function.
Draxler DF; Sashindranath M; Medcalf RL
Semin Thromb Hemost; 2017 Mar; 43(2):143-153. PubMed ID: 27677178
[TBL] [Abstract][Full Text] [Related]
18. Biological mechanisms and individual variation in fibrinolysis after major trauma.
Coats TJ; Morsy M
Emerg Med J; 2020 Mar; 37(3):135-140. PubMed ID: 32001608
[TBL] [Abstract][Full Text] [Related]
19. [Fibrinolytic and fibrin-stabilizing properties of human tissues].
Skipetrov VP
Gematol Transfuziol; 1989 Jun; 34(6):37-41. PubMed ID: 2806865
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolysis in Trauma: "Myth," "Reality," or "Something in Between".
Walsh M; Shreve J; Thomas S; Moore E; Moore H; Hake D; Pohlman T; Davis P; Ploplis V; Piscoya A; Wegner J; Bryant J; Crepinsek A; Lantry J; Sheppard F; Castellino F
Semin Thromb Hemost; 2017 Mar; 43(2):200-212. PubMed ID: 28219085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
